China Resources(Holdings)Co.,Ltd.

China Resources Pharmaceutical Group Limited is listed on the Hong Kong Stock Exchange

Time:2016-10-29Source:CR Pharmaceutical

On the morning of October 28, China Resources Pharmaceutical Group Limited (3320HK) officially announced its initial public offering on the Main Board of Hong Kong Stock Exchange.

Participants to the listing ceremony included Qiu Hong, deputy director of liaison office of the Central People’s Government in the Hong Kong SAR; Sun Xiangyi, general director of the Economic Affairs Department of the Liaison Office; Charles Li, chief executive of Hong Kong Exchanges and Clearing Limited; Wang Jing, deputy general manager of Beijing SCOM Center.

As the sponsors of CRPG (in alphabetic order), Bank of America Merrill Lynch, CCB International (Holdings) Ltd., China International Capital Corporation Ltd and the Goldman Sachs Group also sent their representatives attending the opening ceremony.

The Ceremony also welcomed cornerstone investors from Health & Care Group Ltd.,China Life Insurance Company Ltd., FUJIFILM (China) Investment, Anbang Insurance Group and China Chengtong Holdings Group Ltd.

Fu Yuning, chairman of China Resources Group attended the celebration ceremony along with the management team including Ma Lu, Wang Yin, Wei Bin, Shan Jijing, Zhou Junqing, Wang Chuncheng and Chenying.

Fu Yuning, chairman of China Resources Group (CR Group) and China Resources Pharmaceutical Group (CRPG) and Wang Chuncheng, assistant general manager of CR Group and the Chief Executive Officerand the President of CRPG rang the bell jointly to kick off the launch ceremony.

According to chairman Fu, CRPG’s successful listing on the SEHK landed a major milestone as part of the Group’s development footprint. This move will draw in enormous capital investment for the Group’s bigger growth. Taking this advantage, CRPG aims to become a leading pharmaceutical enterprise in China.

On the evening of October 28, honorable guests including Wang Jing, deputy general manager of Beijing SCOM Center;Sun Xiangyi, general director of the Economic Affairs Department of the Liaison Office in Hong Kong and Fang Chao, director from State-owned Assets Supervision and Administration Commission of the State Council (SASAC) were invited to join a group of over 300 guests to a celebration dinner.

Chairman Fu and general manager Luo Xi, joined by CR Group’s representatives from all functional departments, various business units, first-level profit centers jointly welcomed all guests from CRPG’s sponsors, cornerstone investors and agents.

General manager Luo Xi expressed his gratitude to all attendees for their continuous support to CRPG’s development. As part of the Group’s strategic planning, the successful listing of CRPG showcased its overall efficiency of resources allocation, the embodiment of the positive synergy among the group, and reflects a positive expectation from the community. Luo believes that CRPG can seize this opportunity to provide better products and services to the consumers, and to make a significant contribution to China’s pharmaceutical industry.

After 9 years of making strides since its registration in 2007, CRPG is ranked the second place in China’s pharmaceutical industry. In its first debut of I.P.O., CRPG had captured the attention of both domestic and foreign investors, by offering 1.543 billion of shares at the price of HKD 9.10 per share, with a netting of HKD13.671 billion approximately. The fund raised will be primarily allocated on strategic acquisition, enhancement of the logistic channels, establishing R & D platform, and to reinforce the information technology system and etc.